KIF2A activators represent a class of compounds designed to modulate the activity of the kinesin motor protein KIF2A, a member of the kinesin-13 family. KIF2A plays a crucial role in microtubule dynamics, functioning as a microtubule-depolymerizing motor protein. This class of molecules is engineered to enhance the catalytic activity of KIF2A, facilitating its ability to depolymerize microtubules efficiently. Microtubules are dynamic cytoskeletal structures essential for various cellular processes, including intracellular transport, cell division, and maintenance of cell shape. By influencing the depolymerization dynamics of microtubules, KIF2A activators can impact cellular architecture and contribute to the regulation of intracellular transport processes.
The mechanism underlying KIF2A activation involves the interaction between the activator molecules and specific binding sites on the kinesin motor protein. These activators may enhance the affinity of KIF2A for microtubules, stimulate its ATPase activity, or promote its overall catalytic efficiency. The modulation of KIF2A activity by these compounds can, in turn, influence microtubule dynamics, potentially affecting cellular processes that rely on microtubule organization. Understanding the structural and biochemical details of the interaction between KIF2A and its activators is crucial for unraveling the precise mechanisms through which these compounds exert their effects on microtubule dynamics within the cellular context.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Stabilizes microtubules, potentially stimulating the depolymerizing function of KIF2A. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Disrupts microtubule dynamics by depolymerization, which may provoke the microtubule-depolymerizing activity of KIF2A. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
Interferes with microtubule assembly, potentially prompting the depolymerization function of KIF2A. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Interferes with microtubule polymerization, potentially triggering the depolymerizing activity of KIF2A. | ||||||
Epothilone B, Synthetic | 152044-54-7 | sc-203944 | 2 mg | $176.00 | ||
Stabilizes microtubules similarly to paclitaxel, potentially engaging the depolymerizing function of KIF2A. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits the ERK pathway, which may induce changes in the downstream activation of KIF2A. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits the p38 MAPK pathway, which could potentially prompt changes in KIF2A activation through downstream effects. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits the JNK pathway, potentially instigating changes in KIF2A activation through downstream signaling. | ||||||
Docetaxel | 114977-28-5 | sc-201436 sc-201436A sc-201436B | 5 mg 25 mg 250 mg | $87.00 $332.00 $1093.00 | 16 | |
Stabilizes microtubules, potentially provoking the depolymerizing activity of KIF2A. | ||||||